PF-Atlas › Clinical Trials › NCT01442779
Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
Interferon alpha oral lozenge · Phase 2
Registry ID
NCT01442779
Phase
Phase 2
Status
Completed
Drug / intervention
Interferon alpha oral lozenge
Sponsor
Texas Tech University Health Sciences Center
Start
2000-09
Enrollment
18
Locations
1
About this trial
The purpose of this study is to determine the possible efficacy of low dose, orally administered interferon alpha in subjects with Idiopathic Pulmonary Fibrosis (IPF).
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01442779 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.